Clinical Trial Update: Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of Froniglutide (PF1801) in patients with idiopathic inflammatory myopathies, including dermatomyosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Idiopathic Inflammatory Myopathies
• Polymyositis

Drugs mentioned

• Froniglutide (PF1801)

Snippet

Sponsor: Immunoforge Co. Ltd. | Conditions: Dermatomyositis, Polymyositis | Phase 2 | Status: UNKNOWN